Jünemann K.-P., Aufenanger J., Konrad T., Pill J., Berle B., Persson-Jünemann C., Alken P. The effect of impaired lipid metabolism on the smooth muscle cells of rabbits. Urol. Res., 19:271-275, 1991
Kusterer K., Blöchle C., Konrad T., Palitzsch K.D., Usadel K.-H. Rat liver injury induced by hypoxic ischemia and reperfusion: protective action by somatostatin and two derivatives. Regul. Pept. 44:251-256, 1993
Bloechle C., Kusterer K., Konrad T., Hosch S.B., Izbicki J.R., Knoefel W.T., Broelsch C.E., Usadel K.-H. Rat liver injury induced by hypoxic ischemia and reperfusion: protective action by somatostatins is independent from changes in glucose metabolism. Horm. Metab. Res. 26:270-275, 1994
Angermüller S, Juchem R, Beier K, Konrad T, Kusterer K. Zonal heterogeneity of calcium distribution in rat hepatocytes: An electron microscopic study with a combined glutaraldehyde-osmium-antimonate technique. J. Histochem. Cytochem. 42:593-598, 1994
Konrad T, Blöchle C., Haller G., Brölsch C.E., Usadel K.-H., Kusterer K. Verapamil and flunarizin protect the isolated perfused rat liver against warm ischemia and reperfusion injury. Res. Exp. Med. 1995, 195:61-68
Angermüller S, Schunk M, Kusterer K, Konrad T, Usadel K-H. Alterations of Na+,K+-ATPase activity after hypoxia and reoxygenation in the perfused rat liver: An electron microscopic cytochemical study. J. Hepatol. 22:565-575, 1995
Cieslinski G., Konrad T., Klepzig H.. Comparison of calculated and measured mixed venous oxygen saturation in critically ill patients. Infusionsther.Transfusionsmed. 22:340-343, 1995
Konrad T., Beier K., Kusterer K., Juchem R., Usadel K.-H., Angermüller S. The effect of verapamil on mitochondrial calcium content in normoxic, hypoxic and reoxygenated rat liver. Histochem. J. 29:309-315,1997
Steinmueller T., Konrad T., Vicini P., Toffolo G., Jonas S., Tullius S., Bechstein W.O., Cobelli C., Usadel K.-H., Neuhaus P. Effect of CsA versus FK 506 on insulin sensitivity and insulin response using minimal modeling technique. Transplant.Proc. 30:1452-1453, 1998
Steinmueller T., Konrad T., Jonas S., Tullius S., Bechstein W.O., Mueller A., Platz K.P., Neumann U., Vicini P., Toffolo G., Cobelli C., Usadel K.H., Neuhaus P. The effect of cyclosporine vs. FK 506 on glucose metabolism. Trans. Proc. 31:1129-1130, 1999
Konrad T., Vicini P., Kusterer K., Höflich A., Assadkhani A., Böhles H.J., Sewell A., Tritschler H.J., Cobelli C., Usadel K.-H. a-lipoic acid treatment decreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with NIDDM. Diabetes Care22:280-287, 1999
Konrad T., Vicini P., Zeuzem S., Toffolo G., Briem D., Lormann J., Herrmann G., Wittmann D., Lenz T., Kusterer K., Teuber G., Cobelli C., Usadel K.-H. Interferon-a improves glucose tolerance in diabetic and non-diabetic patients with HCV-induced liver disease. Exp.Clin.Endocrinol.Diabetes 107:343-349, 1999
Konrad T., Steinmüller T, Vicini P, Toffolo G, Grewerus D, Schüller A., Bechstein W.O., Cobelli C., Usadel K.-H., Neuhaus P. Evaluation of insulin sensitivity and b-cell function after liver transplantation: impact of Cyclosporine versus FK 506. Transplantation 10: 2072-2078, 2000
Konrad T., Steinmüller T., Vicini P., Toffolo G, Grewerus D, Schüller A., Bechstein W.O., Usadel K.-H., Cobelli C, Neuhaus P. Evidence for impaired glucose effectiveness in cirrhotic patients after liver transplantation. Metabolism 49:367-372, 2000
Konrad T., Zeuzem S., Vicini P., Toffolo G., Teuber G., Briem D., Lormann J., Lenz T., Herrmann G., Berger A., Cobelli C., Usadel K.-H. The severity of HCV-induced liver damage alters glucose homeostasis in non-cirrhotic patients with chronic HCV infection. Digestion 62:52-59, 2000
Konrad T., Zeuzem S., Vicini P., Toffolo G., Briem D., Lormann J., Herrmann G., Berger A., Kusterer K., Teuber G., Cobelli C., Usadel K.-H. Evaluation of factors controlling glucose tolerance in patients with HCV infection before and after 4 month therapy with Interferon-a
Eur. J. Clin. Invest., 30:111-121, 2000
Konrad T Golling M., Vicini P.,Toffolo G., Wittmann W., Mahon A., Klar E., Cobelli C, Usadel K.-H.,. Insulin sensitivity and beta-cell secretion after liver transplantation in patients with acute liver failure. Tranplant.Proc. 33:2575-2579, 2001
Konrad T., Markus B., Allers C., Vicini P., Toffolo G., Lakos C., Viehmann K., Hanisch E., Encke A., Cobelli C., Usadel K.-H.. Impact of cyclosporin and low dose steroid therapy on insulin sensitivity and beta-cell function in long term liver grafted patients. Transplant. Int. 14:6-11, 2001
Vetter G., Stehling M.K., Langenbeck U., Konrad T. Gentests und hausärztliche Tätigkeit:
Grenzen und Möglichkeiten in der Präventivmedizin Hessisches Ärzteblatt 122002: 686 -688, 2002
Effects of pioglitazone in nondiabetic patients with arterial hypertension: a double-blind, placebo-controlled study. Füllert S, Schneider F, Haak E, Rau H, Badenhoop K, Lübben G, Usadel KH, Konrad T. J. Clin. Endocrinol. Metab. 87:5503-6, 2002
Winkler K, Konrad T, Füllert S, Friedrich I, Destani R, Baumstark MW, Krebs K, Wieland H, März W. Fasting intact proinsulin is a highly specific predictor of insulin resistance in type 2 diabetes. Diabetes Care, 26:2588-94, 2003
Pfützner A, Kunt T, Hohberg C, Mondok A, Pahler S, Konrad T, Lübben G, Forst T. Diabetes Care, 27:682-7, 2004
IRIS II study: the IRIS II score--assessment of a new clinical algorithm for the classification of insulin resistance in patients with Type 2 diabetes.Forst T, Standl E,
Hohberg C, Konrad T, Schulze J, Strotmann HJ, Lübben G, Pahler S, Bachinger A, Langenfeld M, Pfützner A. Diabet. Med. 21:1149-53, 2004
Pioglitazone decreases carotid intima-media thickness independently of glycemic control in patients with type 2 diabetes mellitus: results from a controlled randomized study.Langenfeld MR, Forst T, Hohberg C, Kann P, Lübben G, Konrad T, Füllert S, Sachara C, Pfützner A. Circulation 17;111:2525-31, 2005
No influence of immunosuppression on insulin sensitivity and beta-cell function in living donor liver transplantation.Stockmann M, Nolting S, Konrad T, Hünerbein D, Döbling H, Steinmüller T, Neuhaus P. Transplant Proc. 37:1861-4, 2005
IRIS II study: intact proinsulin is confirmed as a highly specific indicator for insulin resistance in a large cross-sectional study design.Pfützner A, Standl E, Hohberg C, Konrad T, Strotmann HJ, Lübben G, Langenfeld MR, Schulze J, Forst T. Diabetes Technol Ther. 7:478-86, 2005
Improvement of cardiovascular risk markers by pioglitazone is independent from glycemic control: results from the pioneer study. Pfützner A, Marx N, Lübben G, Langenfeld M, Walcher D, Konrad T, Forst T.J. Am. Coll. Cardiol. 45:1925-31, 2005
Pharmacological PPARgamma stimulation in contrast to beta cell stimulation results in an improvement in adiponectin and proinsulin intact levels and reduces intima media thickness in patients with type 2 diabetes.Forst T, Hohberg C, Fuellert S, Lübben G, Konrad T, Löbig M, Weber MM, Sachara C, Gottschall V, Pfützner A. Horm. Metab. Res. 37:521-7, 2005
Pioglitazone lowers blood pressure in hypertensive patients with type 2 diabetes mellitus : an open, multicentre, observational study. Konrad T, Lübben G, Franzen C. Clin. Drug. Investig. 25:337-40, 2005
Major influence of liver function itself but not of immunosuppression determines glucose tolerance after living-donor liver transplantation. Stockmann M, Konrad T, Nolting S, Hünerbein D, Wernecke KD, Döbling H, Steinmüller T, Neuhaus P. Liver Transpl. 12:535-43, 2006
Habitual physical activity and vascular aging in a young to middle-age population at low cardiovascular risk.Kozakova M, Palombo C, Mhamdi L, Konrad T, Nilsson P, Staehr PB, Paterni M, Balkau B; RISC Investigators. Stroke 38:2549-55, 2007
Pharmacodynamic effects of orally administered dexlipotam on endothelial function in type 2-diabetic patients. Vossler S, Füllert S, Schneider F, Haak E, Haak T, Samigullin R, Tritschler H, Tooke JE, Konrad T. Int. J. Clin. Pharmacol. Ther. 45:385-93. 2007
Body composition and common carotid artery remodeling in a healthy population. Kozakova M, Palombo C, Paterni M, Anderwald CH, Konrad T, Colgan MP, Flyvbjerg A, Dekker J; Relationship between Insulin Sensitivity Cardiovascular risk Investigators. J. Clin. Endocrinol. Metab. 93:3325-32, 2008
Investigation of the vascular and pleiotropic effects of atorvastatin and pioglitazone in a population at high cardiovascular risk. Forst T, Wilhelm B, Pfützner A, Fuchs W, Lehmann U, Schaper F, Weber M, Müller J, Konrad T, Hanefeld M. Diab. Vasc. Dis. Res. 5:298-303, 2008
The effect of menopause on carotid artery remodeling, insulin sensitivity, and plasma adiponectin in healthy women.Muscelli E, Kozàkovà M, Flyvbjerg A, Kyriakopoulou K, Astiarraga BD, Glintborg D, Konrad T, Favuzzi A, Petrie J; RISC investigators. Am J Hypertens. 22:364-70, 2009.
Impact of insulin sensitivity treatment with pioglitazone on endothelial function in non-diabetic patients with arterial hypertension.Schneider F, Vossler S, Franke S, Bär F, Konrad T. Int. J. Clin. Pharmacol. Ther. May;47(5):311-20, 2009
Effect of sedentary behaviour and vigorous physical activity on segment-specific carotid wall thickness and its progression in a healthy population. Kozàkovà M, Palombo C, Morizzo C, Nolan JJ, Konrad T, Balkau B; RISC Investigators. Eur. Heart J. 31:1511-9, 2010
One-hour plasma glucose identifies insulin resistance and beta-cell dysfunction in individuals with normal glucose tolerance: cross-sectional data from the Relationship between Insulin Sensitivity and Cardiovascular Risk (RISC) study. Manco M, Panunzi
S, Macfarlane DP, Golay A, Melander O, Konrad T, Petrie JR, Mingrone G; Relationship between Insulin Sensitivity and Cardiovascular Risk (RISC) Consortium. Diabetes Care. 33:2090-7, 2010
Plasma PCSK9 is increased by Fenofibrate and Atorvastatin in a non-additive fashion in diabetic patients. Costet P, Hoffmann MM, Cariou B, Delasalle BG, Konrad T, Winkler K. Atherosclerosis212 :246-51, 2010
Nocturnal blood pressure but not insulin resistance influences endothelial function in treated hypertensive patients. Konrad T, Franke S, Schneider F, Bär F, Vetter G, Winkler K. J. Hum. Hypertens. 25(1):18-24, 2011
Body Weight, Not Insulin Sensitivity or Secretion, May Predict Spontaneous Weight Changes in Nondiabetic and Prediabetic Subjects: The RISC Study. Rebelos E, Muscelli E, Natali A, Balkau B, Mingrone G, Piatti P, Konrad T, Mari A, Ferrannini E; for the RISC Study Investigators. Diabetes 2011 May 26, 2011
Liver Enzymes Are Associated With Hepatic Insulin Resistance, Insulin Secretion, and Glucagon Concentration in Healthy Men and Women. Bonnet F, Ducluzeau PH, Gastaldelli A, Laville M, Anderwald CH, Konrad T, Mari A, Balkau B; for the RISC Study Group. Diabetes 60:1660-1667, 2011
Factors influencing endothelial function in healthy pre- and postmenopausal women Konrad T, Bär F, Schneider F, Franke S, Böhles H, Vetter G, Balkau B Diab.Vasc.Dis.Res. 2011 8: 229-36
Body weight, not insulin sensitivity or secretion, may predict spontaneous weight changes in nondiabetic and prediabetic subjects: the RISC study.
Rebelos E, Muscelli E, Natali A, Balkau B, Mingrone G, Piatti P, Konrad T, Mari A, Ferrannini E; RISC Study Investigators.
Diabetes 60:1938-45, 2011
Bonnet F, Ducluzeau PH, Gastaldelli A, Laville M, Anderwald CH, Konrad T, Mari A, Balkau B; RISC Study Group.
Diabetes 60(6):1660-7, 2011
Ezetimibe alone and in combination lowers the concentration of small, dense low-density lipoproteins in type 2 diabetes mellitus.
Winkler K, Jacob S, Müller-Schewe T, Hoffmann MM, Konrad T.
Atherosclerosis 220:189-93, 2012
From metabolic normality to cardiometabolic risk factors in subjects with obesity.
Bobbioni-Harsch E, Pataky Z, Makoundou V, Laville M, Disse E, Anderwald C, Konrad T, Golay A; RISC Investigators.
Obesity 20:2063-9, 2012
The Association Between Sleep Duration, Insulin Sensitivity, and β-Cell Function: The EGIR-RISC Study.
Rutters F, Besson H, Walker M, Mari A, Konrad T, Nilsson PM, Balkau B, Dekker JM.
J Clin Endocrinol Metab. 101:3272-80, 2016
The relationship between bone turnover and insulin sensitivity and secretion: Cross-sectional and prospective data from the RISC cohort study.
Frost M, Balkau B, Hatunic M, Konrad T, Mingrone G, Højlund K.
Bone, 108:98-105, 2018
Pathophysiological Characteristics Underlying Different Glucose Response Curves: A Latent Class Trajectory Analysis From the Prospective EGIR-RISC Study.
Hulman A, Witte DR, Vistisen D, Balkau B, Dekker JM, Herder C, Hatunic M, Konrad T, Færch K, Manco M.
Diabetes Care 41:1740-1748, 2018
Weitere Koautorenschaften im Rahmen der RISC RISC-Studie
The EGIR-RISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives. Hills SA, Balkau B, Coppack SW, Dekker JM, Mari A, Natali A, Walker M, Ferrannini E; EGIR-RISC Study Group. Diabetologia 47:566-70, 2004
Association of fasting glucagon and proinsulin concentrations with insulin resistance.Ferrannini E, Muscelli E, Natali A, Gabriel R, Mitrakou A, Flyvbjerg A, Golay A, Hojlund K; Relationship between Insulin Sensitivity and Cardiovascular Disease Risk (RISC) Project Investigators. Diabetologia 50:2342-7, 2007
Common variants of the novel type 2 diabetes genes CDKAL1 and HHEX/IDE are associated with decreased pancreatic beta-cell function. Pascoe L, Tura A, Patel SK, Ibrahim IM, Ferrannini E, Zeggini E, Weedon MN, Mari A, Hattersley AT, McCarthy MI, Frayling TM, Walker M; RISC Consortium; U.K. Type 2 Diabetes Genetics Consortium. Diabetes 56:3101-4, 2007
Variation in the ADIPOQ gene promoter is associated with carotid intima media thickness independent of plasma adiponectin levels in healthy subjects. Patel S, Flyvbjerg A, Kozàkovà M, Frystyk J, Ibrahim IM, Petrie JR, Avery PJ, Ferrannini E, Walker M; RISC Investigators. Eur Heart J. 29:386-93, 2007
Influence of the ACE gene insertion/deletion polymorphism on insulin sensitivity and impaired glucose tolerance in healthy subjects. Bonnet F, Patel S, Laville M, Balkau B, Favuzzi A, Monti LD, Lalic N, Walker M; European Group for the Study of Insulin Resistance Relationship Between Insulin Sensitivity and Cardiovascular Disease Risk Study Group. Diabetes Care, 31:789-94, 2008
Physical activity and insulin sensitivity: the RISC study. Balkau B, Mhamdi L, Oppert JM, Nolan J, Golay A, Porcellati F, Laakso M, Ferrannini E; EGIR-RISC Study Group. Diabetes 57:2613-8, 2008
Beta cell glucose sensitivity is decreased by 39% in non-diabetic individuals carrying multiple diabetes-risk alleles compared with those with no risk alleles. Pascoe L, Frayling TM, Weedon MN, Mari A, Tura A, Ferrannini E, Walker M; RISC Consortium. Diabetologia 51:1989-92, 2008
Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population. Gastaldelli A, Kozakova M, Højlund K, Flyvbjerg A, Favuzzi A, Mitrakou A, Balkau B; RISC Investigators. Hepatology 49:1537-44, 2009
Low-grade chronic inflammation in the relationship between insulin sensitivity and cardiovascular disease (RISC) population: associations with insulin resistance and cardiometabolic risk profile.de Rooij SR, Nijpels G, Nilsson PM, Nolan JJ, Gabriel R, Bobbioni-Harsch E, Mingrone G, Dekker JM; Relationship Between Insulin Sensitivity and Cardiovascular Disease (RISC) Investigators. Diabetes Care 32:1295-301. 2009
Fasting insulin has a stronger association with an adverse cardiometabolic risk profile than insulin resistance: the RISC study.de Rooij SR, Dekker JM, Kozakova M, Mitrakou A, Melander O, Gabriel R, Guidone C, Højlund K, Murphy MS, Nijpels G; RISC Group Investigators. Eur J Endocrinol. 161:223-30, 2009
Fat distribution influences the cardio-metabolic profile in a clinically healthy European population.Bobbioni-Harsch E, Pataky Z, Makoundou V, Kozakova M, Dekker J, Golay A; RISC Investigators. Eur J Clin Invest. 39:1055-64, 2009
Beta cell (dys)function in non-diabetic offspring of diabetic patients.Stadler M, Pacini G, Petrie J, Luger A, Anderwald C; RISC Investigators. Diabetologia 52:2435-44, 2009
Common genetic variation in the melatonin receptor 1B gene (MTNR1B) is associated with decreased early-phase insulin response.Langenberg C, Pascoe L, Mari A, Tura A, Laakso M, Frayling TM, Barroso I, Loos RJ, Wareham NJ, Walker M; RISC Consortium. Diabetologia 52:1537-42, 2009
Correlation of the leptin:adiponectin ratio with measures of insulin resistance in non-diabetic individuals. Finucane FM, Luan J, Wareham NJ, Sharp SJ, O'Rahilly S, Balkau B, Flyvbjerg A, Walker M, Højlund K, Nolan JJ; (on behalf of the European Group for the Study of Insulin Resistance: Relationship between Insulin Sensitivity and Cardiovascular Disease Risk Study Group), Savage DB. Diabetologia 52(11):2345-9, 2009
Insulin sensitivity and beta-cell function in the offspring of type 2 diabetic patients: impact of line of inheritance. Natali A, Muscelli E, Mari A, Balkau B, Walker M, Tura A, Anderwald C, Golay A, Ferrannini E; Relationship between Insulin Sensitivity and Cardiovascular disease investigators. J Clin Endocrinol Metab. 95:4703-11, 2010
Impact of family history on relations between insulin resistance, LDL cholesterol and carotid IMT in healthy adults. Anderwald C, Stadler M, Golay A, Krebs M, Petrie J, Luger A; RISC Investigators. Heart 96:1191-200, 2010
a-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population Walter E. Gall, Kirk Beebe, Kay A. Lawton, Klaus-Peter Adam, Matthew W. Mitchell, Pamela J. Nakhle, John A. Ryals, Michael V. Milburn, Monica Nannipieri, Stefania Camastra, Andrea Natali, Ele Ferrannini for the the RISC Study Group PLoS ONE | Volume 5 e10883 - e10883, 2010
Impaired beta cell glucose sensitivity rather than inadequate compensation for insulin resistance is the dominant defect in glucose intolerance Mari A, Tura A, Natali A, Laville M, Laakso M, Gabriel R, Beck-Nielsen H, Ferrannini E; RISC Investigators. Diabetologia 53:749-56, 2010
A novel surrogate index for hepatic insulin resistance. Vangipurapu J, Stančáková A, Kuulasmaa T, Paananen J, Kuusisto J; EGIR-RISC Study Group, Ferrannini E, Laakso M. Diabetologia 54:540-3, 2011
Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study. Ferrannini E, Natali A, Muscelli E, Nilsson PM, Golay A, Laakso M, Beck-Nielsen H, Mari A; RISC Investigators. Diabetologia 54:1507-16, 2011
Fatty liver index, gamma-glutamyltransferase, and early carotid plaques.
Kozakova M, Palombo C, Eng MP, Dekker J, Flyvbjerg A, Mitrakou A, Gastaldelli A, Ferrannini E; RISC Investigators.
Hepatology 55:1406-15, 2012
Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population.
Handberg A, Højlund K, Gastaldelli A, Flyvbjerg A, Dekker JM, Petrie J, Piatti P, Beck-Nielsen H; RISC Investigators.
J Intern Med 271:294-304. 2012
Moderate alcohol consumption is associated with improved insulin sensitivity, reduced basal insulin secretion rate and lower fasting glucagon concentration in healthy women.
Bonnet F, Disse E, Laville M, Mari A, Hojlund K, Anderwald CH, Piatti P, Balkau B; RISC Study Group.
Diabetologia 55:3228-37, 2012
Insulin sensitivity and carotid intima-media thickness: relationship between insulin sensitivity and cardiovascular risk study.
Kozakova M, Natali A, Dekker J, Beck-Nielsen H, Laakso M, Nilsson P, Balkau B, Ferrannini E; RISC Investigators.
Arterioscler Thromb Vasc Biol 33:1409-17, 2013
Depressive symptoms, insulin sensitivity and insulin secretion in the RISC cohort study.
Bot M, Pouwer F, De Jonge P, Nolan JJ, Mari A, Højlund K, Golay A, Balkau B, Dekker JM.
Diabetes Metab. 39:42-9. 2013
Parental history of type 2 diabetes, TCF7L2 variant and lower insulin secretion are associated with incident hypertension. Data from the DESIR and RISC cohorts.
Bonnet F, Roussel R, Natali A, Cauchi S, Petrie J, Laville M, Yengo L, Froguel P, Lange C, Lantieri O, Marre M, Balkau B, Ferrannini E; DESIR and RISC Study Groups.
Diabetologia 56(11):2414-23, 2013
Impact of objectively measured sedentary behaviour on changes in insulin resistance and secretion over 3 years in the RISC study: interaction with weight gain.
Lahjibi E, Heude B, Dekker JM, Højlund K, Laville M, Nolan J, Oppert JM, Balkau B; RISC Study Group.
Diabetes Metab 39:217-25, 2013
Influence of apolipoproteins on the association between lipids and insulin sensitivity: a cross-sectional analysis of the RISC Study.
Baldi S, Bonnet F, Laville M, Morgantini C, Monti L, Hojlund K, Ferrannini E, Natali A; RISC Investigators.
Diabetes Care 36:4125-31, 2013
Euglycemic clamp insulin sensitivity and longitudinal systolic blood pressure: role of sex.
Petrie JR, Malik MO, Balkau B, Perry CG, Højlund K, Pataky Z, Nolan J, Ferrannini E, Natali A; RISC Investigators.
Hypertension 62:404-9, 2013
Common genetic variants highlight the role of insulin resistance and body fat distribution in type 2 diabetes, independent of obesity.
Scott RA, Fall T, Pasko D, Barker A, Sharp SJ, Arriola L, Balkau B, Barricarte A, Barroso I, Boeing H, Clavel-Chapelon F, Crowe FL, Dekker JM, Fagherazzi G, Ferrannini E, Forouhi NG, Franks PW, Gavrila D, Giedraitis V, Grioni S, Groop LC, Kaaks R, Key TJ, Kühn T, Lotta LA, Nilsson PM, Overvad K, Palli D, Panico S, Quirós JR, Rolandsson O, Roswall N, Sacerdote C, Sala N, Sánchez MJ, Schulze MB, Siddiq A, Slimani N, Sluijs I, Spijkerman AM, Tjonneland A, Tumino R, van der A DL, Yaghootkar H; RISC study group; EPIC-InterAct consortium, McCarthy MI, Semple RK, Riboli E, Walker M, Ingelsson E, Frayling TM, Savage DB, Langenberg C, Wareham NJ.
Diabetes 63:4378-4387. 2014
Insulin sensitivity and albuminuria: the RISC study.
Pilz S, Rutters F, Nijpels G, Stehouwer CD, Højlund K, Nolan JJ, Balkau B, Dekker JM; RISC Investigators.
Diabetes Care 37:1597-603, 2014
Response to Comment on Pilz et al. Insulin sensitivity and albuminuria: the RISC study. Diabetes Care 2014;37:1597-1603.
Pilz S, Rutters F, Nijpels G, Stehouwer CD, Højlund K, Nolan JJ, Balkau B, Dekker JM; RISC Investigators.
Diabetes Care 38:e31 2015:
Influence of endogenous NEFA on beta cell function in humans.
Rebelos E, Seghieri M, Natali A, Balkau B, Golay A, Piatti PM, Lalic NM, Laakso M, Mari A, Ferrannini E.
Diabetologia 58:2344-51, 2015
Elevated heart rate predicts β cell function in non-diabetic individuals: the RISC cohort.
Bonnet F, Empana JP, Natali A, Monti L, Golay A, Lalic K, Dekker J, Mari A, Balkau B; RISC Study Group.
Eur J Endocrinol. 173:409-15, 2015
Gamma-glutamyltransferase, fatty liver index and hepatic insulin resistance are associated with incident hypertension in two longitudinal studies.
Bonnet F, Gastaldelli A, Pihan-Le Bars F, Natali A, Roussel R, Petrie J, Tichet J, Marre M, Fromenty B, Balkau B; D.E.S.I.R., RISC Study Groups.
J Hypertens 35:493-500, 2017
Insulin resistance and β-cell function in smokers: results from the EGIR-RISC European multicentre study.
Gottsäter M, Balkau B, Hatunic M, Gabriel R, Anderwald CH, Dekker J, Lalic N, Nilsson PM.
Diabet Med. 34:223-228, 2017
Plasma HDL-cholesterol and triglycerides, but not LDL-cholesterol, are associated with insulin secretion in non-diabetic subjects.
Natali A, Baldi S, Bonnet F, Petrie J, Trifirò S, Tricò D, Mari A; RISC Investigators.
Metabolism 69:33-42, 2017
Renal function markers and insulin sensitivity after 3years in a healthy cohort, the EGIR-RISC study.
Siméon S, Massy Z, Højlund K, Lalic K, Porcellati F, Dekker J, Petrie J, Currie G, Balkau B.
BMC Nephrol 31;19:124. 2018
High density lipoprotein with apolipoprotein C-III is associated with carotid intima-media thickness among generally healthy individuals.
Yamamoto R, Sacks FM, Hu FB, Rosner B, Furtado JD, Aroner SA, Ferrannini E, Baldi S, Kozakova M, Balkau B, Natali A, Jensen MK; RISC Investigators.
Atherosclerosis 269:92-99, 2018
One hour post-load plasma glucose and 3 year risk of worsening fasting and 2hour glucose tolerance in the RISC cohort.
Manco M, Mari A, Petrie J, Mingrone G, Balkau B; EGIR-RISC study group.
Diabetologia Mar;62(3):544-548. 2019